ECOC — ABVC BIOPHARMA, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1173313 ·
Last close
$0.05
Market Cap
—
52W High
—
52W Low
—
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,765 | 0 | -1,572,472 | -1,560,242 | 19,732,528 | 140,324 | 6,904,071 |
| Sep 2025 | 795,950 | 795,950 | -1,168,410 | -1,246,513 | 21,176,299 | 192,068 | 6,683,592 |
| Jun 2025 | 19,139 | 0 | -2,294,983 | -2,257,022 | 16,241,060 | 388,251 | 6,751,327 |
| Mar 2025 | 19,071 | 0 | -693,005 | -842,075 | 14,875,699 | 152,206 | 6,919,404 |
Annual Trend (SEC EDGAR, last 10y)
Revenues vs Net Income (last 10y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 167,103 | -7,151,259 | -7,908,554 | 21,062,203 | 7,764,723 | 13,297,480 | — |
| Dec 2024 | 509,589 | -4,705,242 | -4,902,878 | 7,539,907 | 6,815,948 | 723,959 | — |
| Dec 2023 | 152,430 | -8,216,509 | -10,515,656 | 14,492,599 | 6,361,627 | 8,130,972 | — |
| Dec 2022 | 969,783 | -15,114,412 | -16,423,239 | 9,855,475 | 6,619,336 | 3,236,139 | — |
| Dec 2021 | 355,797 | -11,705,968 | -12,035,851 | 13,698,033 | 4,827,691 | 8,870,342 | — |
| Dec 2020 | 483,045 | -8,505,776 | -10,593,584 | 11,606,705 | 8,944,638 | 2,662,067 | — |
| Dec 2019 | 701,719 | -3,458,778 | -3,933,240 | 6,927,811 | 7,052,628 | -124,817 | — |
| Dec 2018 | 93 | -1,393,616 | -4,101,303 | 96,273 | 5,845,691 | -5,749,418 | — |
| Sep 2017 | 149 | -3,996,342 | -4,071,983 | 2,754,851 | 4,147,914 | -1,393,063 | — |
| Sep 2016 | 361 | -4,497,295 | -4,507,799 | 177,352 | 56,470 | 120,882 | — |
TTM Snapshot
Revenues TTM
$151,797
NetIncome TTM
$-8,626,721
OpCashFlow TTM
—
Assets (Latest)
$19,732,528
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.03T | $1157.49 | — |
| JNJ | JOHNSON & JOHNSON | $613.99B | $254.78 | — |
| ABBV | AbbVie Inc. | $471.27B | $266.69 | — |
| MRK | Merck & Co., Inc. | $350.19B | $141.94 | — |
| NVS | NOVARTIS AG | $267.60B | $140.79 | — |
Recent Insider Activity
No insider activity indexed for this ticker.